15388 results for "1 mil coins fc 26 Visit Buyfc26coins.com for latest FC 26 coins news..buoc"

in 83.55 milliseconds.

• Genome and transcriptome sequence data from a metastatic breast cancer ER+ patient

  Genome and transcriptome sequence data from a metastatic breast cancer ER+ patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

  Dataset EGAD00001004631

• Genome and transcriptome sequence data from a metastatic breast carcinoma patient

  Genome and transcriptome sequence data from a metastatic breast carcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

  Dataset EGAD00001004632

• Genome and transcriptome sequence data from a metastatic renal carcinoma patient

  Genome and transcriptome sequence data from a metastatic renal carcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

  Dataset EGAD00001004633

• Genome and transcriptome sequence data from a metastatic adenocarcinoma of the lung patient

  Genome and transcriptome sequence data from a metastatic adenocarcinoma of the lung patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

  Dataset EGAD00001004634

• 33 patients with Monoclonal Gammopathy of Undetermined Significance (MGUS)

  Monoclonal gammopathy of undetermined significance (MGUS) is a premalignant precursor of multiple myeloma (MM) with a 1% risk of progression per year. Although targeted analyses have shown the presence of specific genetic abnormalities such as IGH translocations, RB1 deletion, 1q gain, hyperdiploidy or RAS genes mutations, little is known about molecular mechanism of malignant transformation. We have performed whole exome sequencing together with SNP array analysis in 33 flow-cytometry separated abnormal PC samples of MGUS patients to describe somatic gene mutations and chromosome changes at the genome-wide level. Non-synonymous mutations (NS-SNVs) and copy number alterations (CNAs) were present in 97.0% and in 63.6% of cases, respectively. Importantly, the number of somatic mutations was significantly lower in MGUS compared to MM (p<10-4) and we have identified 6 myeloma significantly mutated genes which are KRAS, NRAS, DIS3, HIST1H1E, EGR1 and LTB in the MGUS dataset. We also found a positive correlation with increasing chromosome changes and somatic mutations. IGH translocations were present in 27.3% of cases comprising t(4;14), t(11;14), t(14;16) or t(14;20) and were in a similar frequency to MM, which corresponded with primary lesion hypothesis. Data from this study showed MGUS is a genetically comprehensive disease, however overall genetic instability is significantly lower compared to MM.

  Dataset EGAD00001001901

• UK10K_OBESITY_SCOOP UK10K_EXOME_EXTRAS

  UK10K_OBESITY_SCOOP UK10K_EXOME_EXTRAS

  Dataset EGAD00001000756

• UK10K_RARE_NMWG REL-2013-03-06

  UK10K_RARE_NMWG REL-2013-03-06

  Dataset EGAD00001000804

• Genome and transcriptome sequence data from a metastatic adenoid cystic carcinoma of the breast patient

  Genome and transcriptome sequence data from a metastatic adenoid cystic carcinoma of the breast patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

  Dataset EGAD00001004921

• Genome and transcriptome sequence data from a squamous cell carcinoma of the alveolar ridge patient

  Genome and transcriptome sequence data from a squamous cell carcinoma of the alveolar ridge patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

  Dataset EGAD00001004934

• The mutational landscape of normal human endometrial epithelium - Additional Samples

  All normal somatic cells are thought to acquire mutations but understanding of the rates, patterns, causes and consequences of somatic mutation in normal cells is limited. Uterine endometrium adopts multiple physiological states over a lifetime and is lined by a gland-forming epithelium. Whole genome sequencing of normal endometrial glands from women aged 19 to 81 years showed them to be clonal cell populations derived from recent common ancestors, with total mutation burdens that increase with age at ~29 base substitutions/year and which are many-fold lower than endometrial cancers. Normal endometrial glands frequently carry driver mutations in cancer genes. Driver mutation burdens increase with age and correlate negatively with parity. Phylogenetic trees of normal endometrial glands constructed using whole genome sequences indicated that clones with drivers often originate during the first decades and spread to colonise the endometrial epithelial lining. The results show that driver mutation landscapes differ between normal cell types, perhaps shaped by differences in normal tissue physiology, and suggest that the procession of neoplastic changes leading to endometrial cancer is initiated early in life.

  Dataset EGAD00001005214

• BARIA 100 transcriptomics

  BARIA 100

  Dataset EGAD00001009092

• Genome and transcriptome sequence data from a metastatic pancreatic adenocarcinoma patient

  Genome and transcriptome sequence data from a metastatic pancreatic adenocarcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

  Dataset EGAD00001008925

• Genome and transcriptome sequence data from a lung adenocarcinoma patient

  Genome and transcriptome sequence data from a lung adenocarcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

  Dataset EGAD00001008926

• Genome and transcriptome sequence data from a multiple myeloma patient

  Genome and transcriptome sequence data from a multiple myeloma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

  Dataset EGAD00001008947

• Genome and transcriptome sequence data from a carcinoma of unknown primary patient

  Genome and transcriptome sequence data from a carcinoma of unknown primary patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

  Dataset EGAD00001008927

• Genome and transcriptome sequence data from a pancreatic adenocarcinoma patient

  Genome and transcriptome sequence data from a pancreatic adenocarcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

  Dataset EGAD00001008928

• Genome and transcriptome sequence data from a hepatocellular carcinoma patient

  Genome and transcriptome sequence data from a hepatocellular carcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

  Dataset EGAD00001008929

• Genome and transcriptome sequence data from a adrenocortical carcinoma patient

  Genome and transcriptome sequence data from a adrenocortical carcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

  Dataset EGAD00001008930

• Genome and transcriptome sequence data from a metastatic pancreatic adenocarcinoma patient

  Genome and transcriptome sequence data from a metastatic pancreatic adenocarcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

  Dataset EGAD00001008931

• Genome and transcriptome sequence data from a mucosal melanoma patient

  Genome and transcriptome sequence data from a mucosal melanoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

  Dataset EGAD00001008932

• Genome and transcriptome sequence data from a carcinoma of unknown primary patient

  Genome and transcriptome sequence data from a carcinoma of unknown primary patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

  Dataset EGAD00001008916

• Genome and transcriptome sequence data from a pancreatic acinar cell adenocarcinoma patient

  Genome and transcriptome sequence data from a pancreatic acinar cell adenocarcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

  Dataset EGAD00001008934

• Genome and transcriptome sequence data from a metastatic pancreatic adenocarcinoma patient

  Genome and transcriptome sequence data from a metastatic pancreatic adenocarcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

  Dataset EGAD00001008915

• Genome and transcriptome sequence data from a metastatic pancreatic adenocarcinoma patient

  Genome and transcriptome sequence data from a metastatic pancreatic adenocarcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

  Dataset EGAD00001008914

• Genome and transcriptome sequence data from a metastatic pancreatic adenocarcinoma patient

  Genome and transcriptome sequence data from a metastatic pancreatic adenocarcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

  Dataset EGAD00001008913

• Genome and transcriptome sequence data from a metastatic synovial sarcoma patient

  Genome and transcriptome sequence data from a metastatic synovial sarcoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

  Dataset EGAD00001008912

• Genome and transcriptome sequence data from a Ewing sarcoma patient

  Genome and transcriptome sequence data from a Ewing sarcoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

  Dataset EGAD00001008911

• Genome and transcriptome sequence data from a neuroendocrine tumor patient

  Genome and transcriptome sequence data from a neuroendocrine tumor patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

  Dataset EGAD00001008910

• Genome and transcriptome sequence data from a colorectal cancer patient

  Genome and transcriptome sequence data from a colorectal cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

  Dataset EGAD00001008909

• Genome and transcriptome sequence data from a pancreatic adenocarcinoma patient

  Genome and transcriptome sequence data from a pancreatic adenocarcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

  Dataset EGAD00001008933

• Genome and transcriptome sequence data from a nasopharynx carcinoma patient

  Genome and transcriptome sequence data from a nasopharynx carcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

  Dataset EGAD00001008917

• Genome and transcriptome sequence data from a pancreatic ductal adenocarcinoma patient

  Genome and transcriptome sequence data from a pancreatic ductal adenocarcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

  Dataset EGAD00001008918

• Genome and transcriptome sequence data from a pancreatic adenocarcinoma patient

  Genome and transcriptome sequence data from a pancreatic adenocarcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

  Dataset EGAD00001008919

• Genome and transcriptome sequence data from a tongue squamous cell carcinoma patient

  Genome and transcriptome sequence data from a tongue squamous cell carcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

  Dataset EGAD00001008920

• Genome and transcriptome sequence data from a endometrial carcinoma patient

  Genome and transcriptome sequence data from a endometrial carcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

  Dataset EGAD00001008921

• Genome and transcriptome sequence data from a intrahepatic cholangiocarcinoma patient

  Genome and transcriptome sequence data from a intrahepatic cholangiocarcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

  Dataset EGAD00001008922

• Genome and transcriptome sequence data from a metastatic pancreatic adenocarcinoma patient

  Genome and transcriptome sequence data from a metastatic pancreatic adenocarcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

  Dataset EGAD00001008923

• Genome and transcriptome sequence data from a metastatic pancreatic adenocarcinoma patient

  Genome and transcriptome sequence data from a metastatic pancreatic adenocarcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

  Dataset EGAD00001008924

• Genome and transcriptome sequence data from a clear cell adenocarcinoma patient

  Genome and transcriptome sequence data from a clear cell adenocarcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

  Dataset EGAD00001008940

• Genome and transcriptome sequence data from a paraganglioma patient

  Genome and transcriptome sequence data from a paraganglioma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

  Dataset EGAD00001008935

• Genome and transcriptome sequence data from a thoracic cancer patient

  Genome and transcriptome sequence data from a thoracic cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

  Dataset EGAD00001008936

• Genome and transcriptome sequence data from a salivary gland carcinoma patient

  Genome and transcriptome sequence data from a salivary gland carcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

  Dataset EGAD00001008937

• Genome and transcriptome sequence data from a lung adenocarcinoma patient

  Genome and transcriptome sequence data from a lung adenocarcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

  Dataset EGAD00001008938

• Genome and transcriptome sequence data from a neuroendocrine tumor patient

  Genome and transcriptome sequence data from a neuroendocrine tumor patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

  Dataset EGAD00001008939

• Genome and transcriptome sequence data from a cholangiocarcinoma patient

  Genome and transcriptome sequence data from a cholangiocarcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

  Dataset EGAD00001008941

• Genome and transcriptome sequence data from a breast carcinoma patient

  Genome and transcriptome sequence data from a breast carcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

  Dataset EGAD00001008942

• Genome and transcriptome sequence data from a melanoma patient

  Genome and transcriptome sequence data from a melanoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

  Dataset EGAD00001008943

• Genome and transcriptome sequence data from a hematopoietic or lymphoreticular systems myeloma-multiple patient

  Genome and transcriptome sequence data from a hematopoietic or lymphoreticular systems myeloma-multiple patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

  Dataset EGAD00001008944

• Genome and transcriptome sequence data from a carcinoma of unknown primary patient

  Genome and transcriptome sequence data from a carcinoma of unknown primary patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

  Dataset EGAD00001008945

• Genome and transcriptome sequence data from a neuroendocrine carcinoma patient

  Genome and transcriptome sequence data from a neuroendocrine carcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

  Dataset EGAD00001008946

• Genome and transcriptome sequence data from a pancreatic adenocarcinoma patient

  Genome and transcriptome sequence data from a pancreatic adenocarcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

  Dataset EGAD00001008948

• Targeted capture ctDNA Library CRCQV42Run017-24

  Targeted capture ctDNA Library CRCQV42Run017-24 from patient PBC0002294, TNBC FFPE sample

  Dataset EGAD00001010414

• Targeted capture ctDNA Library CRCQV42Run018-18

  Targeted capture ctDNA Library CRCQV42Run018-18 from patient PBC0001859, TNBC FFPE sample

  Dataset EGAD00001010417

• Targeted capture ctDNA Library CRCQV42Run019-21

  Targeted capture ctDNA Library CRCQV42Run019-21 from patient PBC0001310, TNBC FFPE sample

  Dataset EGAD00001010422

• Targeted capture ctDNA Library CRCQV42Run019-6

  Targeted capture ctDNA Library CRCQV42Run019-6 from patient PBC0001295, TNBC FFPE sample

  Dataset EGAD00001010423

• Targeted capture ctDNA Library CRCQV42Run019-8

  Targeted capture ctDNA Library CRCQV42Run019-8 from patient PBC0001304, TNBC FFPE sample

  Dataset EGAD00001010424

• Targeted capture ctDNA Library CRCQV42Run020-4

  Targeted capture ctDNA Library CRCQV42Run020-4 from patient PBC0001312, TNBC FFPE sample

  Dataset EGAD00001010430

• Targeted capture ctDNA Library CRCQV42Run020-5

  Targeted capture ctDNA Library CRCQV42Run020-5 from patient PBC0001315, TNBC FFPE sample

  Dataset EGAD00001010431

• Targeted capture ctDNA Library CRCQV42Run021-10

  Targeted capture ctDNA Library CRCQV42Run021-10 from patient PBC0001470, TNBC FFPE sample

  Dataset EGAD00001010433

• Targeted capture ctDNA Library CRCQV42Run021-11

  Targeted capture ctDNA Library CRCQV42Run021-11 from patient PBC0001516, TNBC FFPE sample

  Dataset EGAD00001010434

• Targeted capture ctDNA Library CRCQV42Run021-12

  Targeted capture ctDNA Library CRCQV42Run021-12 from patient PBC0001653, TNBC FFPE sample

  Dataset EGAD00001010435

• Targeted capture ctDNA Library CRCQV42Run029-11

  Targeted capture ctDNA Library CRCQV42Run029-11 from patient PBC0001353, TNBC FFPE sample

  Dataset EGAD00001010511

• Targeted capture ctDNA Library CRCQV42Run029-5

  Targeted capture ctDNA Library CRCQV42Run029-5 from patient PBC0002533, TNBC FFPE sample

  Dataset EGAD00001010518

• Targeted capture ctDNA Library CRCQV42Run029-7

  Targeted capture ctDNA Library CRCQV42Run029-7 from patient PBC0004173, TNBC FFPE sample

  Dataset EGAD00001010519

• Targeted capture ctDNA Library CRCQV42Run021-4

  Targeted capture ctDNA Library CRCQV42Run021-4 from patient PBC0001328, TNBC FFPE sample

  Dataset EGAD00001010446

• Targeted capture ctDNA Library CRCQV42Run021-7

  Targeted capture ctDNA Library CRCQV42Run021-7 from patient PBC0001299, TNBC FFPE sample

  Dataset EGAD00001010448

• Targeted capture ctDNA Library CRCQV42Run021-9

  Targeted capture ctDNA Library CRCQV42Run021-9 from patient PBC0001323, TNBC FFPE sample

  Dataset EGAD00001010449

• Targeted capture ctDNA Library CRCQV42Run022-19

  Targeted capture ctDNA Library CRCQV42Run022-19 from patient PBC0002680, plasma 6 month repeat sample

  Dataset EGAD00001010454

• Targeted capture ctDNA Library CRCQV42Run022-20

  Targeted capture ctDNA Library CRCQV42Run022-20 from patient PBC0001845, plasma 12 month repeat sample

  Dataset EGAD00001010455

• Targeted capture ctDNA Library CRCQV42Run022-22

  Targeted capture ctDNA Library CRCQV42Run022-22 from patient PBC0002062, plasma 12 month repeat sample

  Dataset EGAD00001010456

• Targeted capture ctDNA Library CRCQV42Run022-6

  Targeted capture ctDNA Library CRCQV42Run022-6 from patient PBC0002406, TNBC FFPE sample

  Dataset EGAD00001010457

• Targeted capture ctDNA Library CRCQV42Run022-7

  Targeted capture ctDNA Library CRCQV42Run022-7 from patient PBC0002744, TNBC FFPE sample

  Dataset EGAD00001010458

• Targeted capture ctDNA Library CRCQV42Run022-8

  Targeted capture ctDNA Library CRCQV42Run022-8 from patient PBC0002826, TNBC FFPE sample

  Dataset EGAD00001010459

• Targeted capture ctDNA Library CRCQV42Run023-19

  Targeted capture ctDNA Library CRCQV42Run023-19 from patient PBC0002383, plasma baseline repeat sample

  Dataset EGAD00001010462

• Targeted capture ctDNA Library CRCQV42Run023-20

  Targeted capture ctDNA Library CRCQV42Run023-20 from patient PBC0001224, plasma baseline repeat sample

  Dataset EGAD00001010463

• Targeted capture ctDNA Library CRCQV42Run024-11

  Targeted capture ctDNA Library CRCQV42Run024-11 from patient PBC0001306, TNBC FFPE sample

  Dataset EGAD00001010465

• Targeted capture ctDNA Library CRCQV42Run024-13

  Targeted capture ctDNA Library CRCQV42Run024-13 from patient PBC0001306, TNBC FFPE sample

  Dataset EGAD00001010466

• Targeted capture ctDNA Library CRCQV42Run024-14

  Targeted capture ctDNA Library CRCQV42Run024-14 from patient PBC0002853, TNBC FFPE sample

  Dataset EGAD00001010467

• Targeted capture ctDNA Library CRCQV42Run024-16

  Targeted capture ctDNA Library CRCQV42Run024-16 from patient PBC0003641, TNBC FFPE sample

  Dataset EGAD00001010468

• Targeted capture ctDNA Library CRCQV42Run025-10

  Targeted capture ctDNA Library CRCQV42Run025-10 from patient PBC0001335, TNBC FFPE sample

  Dataset EGAD00001010476

• Targeted capture ctDNA Library CRCQV42Run025-11

  Targeted capture ctDNA Library CRCQV42Run025-11 from patient PBC0003595, TNBC FFPE sample

  Dataset EGAD00001010477

• Targeted capture ctDNA Library CRCQV42Run025-19

  Targeted capture ctDNA Library CRCQV42Run025-19 from patient PBC0003364, TNBC FFPE sample

  Dataset EGAD00001010482

• Targeted capture ctDNA Library CRCQV42Run025-5

  Targeted capture ctDNA Library CRCQV42Run025-5 from patient PBC0001589, TNBC FFPE sample

  Dataset EGAD00001010483

• Targeted capture ctDNA Library CRCQV42Run025-6

  Targeted capture ctDNA Library CRCQV42Run025-6 from patient PBC0003014, TNBC FFPE sample

  Dataset EGAD00001010484

• Targeted capture ctDNA Library CRCQV42Run025-7

  Targeted capture ctDNA Library CRCQV42Run025-7 from patient PBC0003334, TNBC FFPE sample

  Dataset EGAD00001010485

• Targeted capture ctDNA Library CRCQV42Run025-8

  Targeted capture ctDNA Library CRCQV42Run025-8 from patient PBC0003385, TNBC FFPE sample

  Dataset EGAD00001010486

• Targeted capture ctDNA Library CRCQV42Run026-14

  Targeted capture ctDNA Library CRCQV42Run026-14 from patient PBC0003587, TNBC FFPE sample

  Dataset EGAD00001010487

• Targeted capture ctDNA Library CRCQV42Run026-15

  Targeted capture ctDNA Library CRCQV42Run026-15 from patient PBC0002872, TNBC FFPE sample

  Dataset EGAD00001010488

• Targeted capture ctDNA Library CRCQV42Run026-16

  Targeted capture ctDNA Library CRCQV42Run026-16 from patient PBC0005064, TNBC FFPE sample

  Dataset EGAD00001010489

• Targeted capture ctDNA Library CRCQV42Run026-17

  Targeted capture ctDNA Library CRCQV42Run026-17 from patient PBC0003643, TNBC FFPE sample

  Dataset EGAD00001010490

• Targeted capture ctDNA Library CRCQV34Run005-4

  Targeted capture ctDNA Library CRCQV34Run005-4 from patient PBC0001627, TNBC FFPE sample

  Dataset EGAD00001010349

• Targeted capture ctDNA Library CRCQV34Run005-15

  Targeted capture ctDNA Library CRCQV34Run005-15 from patient PBC0002824, TNBC FFPE sample

  Dataset EGAD00001010346

• Targeted capture ctDNA Library CRCQV34Run005-18

  Targeted capture ctDNA Library CRCQV34Run005-18 from patient PBC0001845, TNBC FFPE sample

  Dataset EGAD00001010347

• Targeted capture ctDNA Library CRCQV34Run005-20

  Targeted capture ctDNA Library CRCQV34Run005-20 from patient PBC0002680, TNBC FFPE sample

  Dataset EGAD00001010348

• Targeted capture ctDNA Library CRCQV34Run005-5

  Targeted capture ctDNA Library CRCQV34Run005-5 from patient PBC0002062, TNBC FFPE sample

  Dataset EGAD00001010350

• Targeted capture ctDNA Library CRCQV34Run005-8

  Targeted capture ctDNA Library CRCQV34Run005-8 from patient PBC0002108, TNBC FFPE sample

  Dataset EGAD00001010351

• Targeted capture ctDNA Library CRCQV34Run005-9

  Targeted capture ctDNA Library CRCQV34Run005-9 from patient PBC0002429, TNBC FFPE sample

  Dataset EGAD00001010352

• Targeted capture ctDNA Library CRCQV34Run007-24

  Targeted capture ctDNA Library CRCQV34Run007-24 from patient PBC0001051, TNBC FFPE sample

  Dataset EGAD00001010361

• Targeted capture ctDNA Library CRCQV34Run015-20

  Targeted capture ctDNA Library CRCQV34Run015-20 from patient PBC0001432, TNBC FFPE sample

  Dataset EGAD00001010382

• Targeted capture ctDNA Library CRCQV34Run015-22

  Targeted capture ctDNA Library CRCQV34Run015-22 from patient PBC0001673, TNBC FFPE sample

  Dataset EGAD00001010383